International Journal of Cancer

Papers
(The H4-Index of International Journal of Cancer is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
189
Issue Information181
152
Issue Information139
Issue Information110
Issue Information100
Cervical cancer screening: Sharing best practices and addressing common challenges in cervical cancer screening programs97
Erratum96
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study93
Education level and risk of breast cancer by tumor subtype in the EPIC cohort91
Maternal illnesses during pregnancy and the risk of childhood cancer: A medical‐record based analysis (UKCCS)78
Issue Information78
The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center76
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities72
Issue Information69
65
Comments on “Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer”63
Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population62
Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration d61
Mammographic breast density, body mass index and risk of breast cancer in Korean women aged 75 years and older60
Ovarian cancer survival in sub‐Saharan Africa by human development index and histological subtypes: A population‐based registry study58
Improving colon cancer screening in Poland. In search of the Holy Grail56
Immune‐related conditions and cancer‐specific mortality among older adults with cancer in the United States55
Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization54
The landscape of genetic aberrations in myxofibrosarcoma53
tRNA‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression52
Association of aflatoxin with gallbladder cancer in a case‐control study nested within a Chinese cohort52
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials52
Assessment of long‐term survival in childhood cancer patients using cancer registry data from eastern China: Period analysis outperforms traditional analysis51
Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC)51
A comprehensive investigation of histotype‐specific microRNA and their variants in Stage I epithelial ovarian cancers51
Ramucirumab‐containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum‐based chemotherapy: A multicenter observational retrospective study (W50
Association between fish oil supplementation and cancer risk according to fatty fish consumption: A large prospective population‐based cohort study using UK Biobank50
Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population‐based patient cohort study in southern China50
Socioeconomic position and risk of cervical cancer in the Nordic countries: Results from the Nordic Occupational Cancer Study50
Pre‐diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study47
47
Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk46
Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study46
Changes in cancer incidence rates by stage during the COVID‐19 pandemic in the US45
DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target45
Timing of surgery and 1‐year postoperative outcomes in patients with breast cancer and preoperative COVID‐19 history: A matched, longitudinal, ambidirectional cohort study44
Mediation effect of intestinal microbiota on the relationship between fiber intake and colorectal cancer44
The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV‐associated tumors: A review44
0.34743094444275